NCT07338500 Cardiovascular Effects of Music Versus Guided Mindfulness
| NCT ID | NCT07338500 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sir Mortimer B. Davis - Jewish General Hospital |
| Condition | Music Listening Intervention |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2026-04-10 |
| Primary Completion | 2026-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2026-04-10 with a primary completion date of 2026-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to examine how listening to music compares to guided mindfulness in affecting blood pressure, heart rate, and feelings of anxiety in healthy adults. The investigators aim to determine whether one of these approaches is more effective in reducing these variables. Additionally, the study will explore whether personal traits or preferences, measured using questionnaires, influence how participants respond to music or mindfulness. Based on previous clinical findings, the researchers hypothesize that listening to music will lead to greater reductions in blood pressure and heart rate compared to guided mindfulness.
Eligibility Criteria
Inclusion Criteria: * Normal baseline blood pressure (systolic BP \< 120 mmHg and diastolic BP \< 80mmHg). * Abstention from caffeine intake for at least 12 hours before the study session and throughout the session, as caffeine may influence cardiovascular measurements. * Abstention from using nicotine or tobacco products for at least 1 hour before the study session and throughout the session, as these substances may influence cardiovascular measurements. Exclusion Criteria: * Significant hearing impairments that cannot be improved with hearing aids or sound amplification. * Current use of medications that could affect blood pressure. * History of hypertension or cardiovascular disease. * Diagnosis of active substance use disorder, or reported patterns of alcohol, cannabis, or recreational/non-prescribed substance use likely to affect cardiovascular function.
Contact & Investigator
Kyle Greenway, MD
PRINCIPAL INVESTIGATOR
Sir Mortimer B. Davis - Jewish General Hospital, McGill University
Frequently Asked Questions
Who can join the NCT07338500 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Music Listening Intervention. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07338500 currently recruiting?
Yes, NCT07338500 is actively recruiting participants. Contact the research team at elizabeth.misener@mail.mcgill.ca for enrollment information.
Where is the NCT07338500 trial being conducted?
This trial is being conducted at Montreal, Canada.
Who is sponsoring the NCT07338500 clinical trial?
NCT07338500 is sponsored by Sir Mortimer B. Davis - Jewish General Hospital. The principal investigator is Kyle Greenway, MD at Sir Mortimer B. Davis - Jewish General Hospital, McGill University. The trial plans to enroll 30 participants.